SEC Form 4 · accession 0001638599-17-000701
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Takashi Kei Kishimoto
Officer — Chief Scientific Officer
Period of report
Jul 7, 2017
Accepted (ET)
Jul 11, 2017 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.33 | Jul 7, 2017 | A | 40,000 | A | — | Jul 6, 2027 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1This option vests as to 25% of the shares on June 16, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter.